NPI registry status
Active
2026 NPPES data Medical Oncology Physician NPI 1063402998 MD
Verify on CMS → Shantae Lucas, MD
Medical Oncology Physician in Asheville, North Carolina.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 3,815 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 207 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
79%
generic claims · 21% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · Above neutral
Industry payments
$814.32
36 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Shantae Lucas, MD reported a CMS MIPS final score of 75/100 - below the 83.1 national average - and filed 1,009 Medicare Part D claims in 2023.
- 75/100
- MIPS score · -8 vs avg
- 1K
- Part D claims, 2023
- 79%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Shantae Lucas, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
75 15th percentile higher than 15% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Shantae Lucas, MD sits
This provider among medical oncology physician peers
Across the 1,527 medical oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Shantae Lucas, MD writes more Part D claims than 73% of them and scores higher on MIPS quality than 11% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one medical oncology physician peer from a representative sample of 60; the gold marker is Shantae Lucas, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Shantae Lucas, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Shantae Lucas, MD?
Below national averagePrimary specialty
Medical Oncology Physician
Medicare Part D claims
1,009 46% vs specialty avg
MIPS final score
75/100 8.1 pts vs avg
Specialty distribution in North Carolina
How Medical Oncology Physician compares to other specialties among North Carolina providers
Medicare quality performance, MIPS
Shantae Lucas, MD's 2023 MIPS final score plotted against the Medical Oncology Physician national average
- MIPS Final Score
- 75/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Medical Oncology Physician) - 75/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Shantae Lucas, MD appears in the CMS NPPES registry as a Medical Oncology Physician provider holding MD credentials at 551 BREVARD RD, Asheville, NC, 28806, with a listed phone of (828) 212-7021. NPI 1063402998 was issued on 10/22/2005.
Medicare Part D records for calendar year 2023 show 1,009 prescription claims written by this provider, covering 207 Medicare beneficiaries and totaling roughly $2.3 million in drug spend, split 21% brand-name and 79% generic by claim count, with an opioid prescribing rate of 3.1%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.
Medical Oncology Physician is a narrow specialty nationwide, with 3,815 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1063402998 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 10/22/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
Avg: 83.1
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Shantae Lucas, MD. Source: openpaymentsdata.cms.gov.
Total received
$814
Largest payer
Novartis Pharmaceuticals Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
Shantae Lucas, MD - brand share 21.0%
Medical Oncology Physician average
21% brand-name claims vs 79% generic, on 1,009 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,009
Total Claims
$2.3M
Total Drug Cost
207
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,642
- Total Day Supply
- 46,596
- Brand vs Generic
- 21% brand / 79% generic
- Brand Drug Cost
- $2.2M
- Generic Drug Cost
- $119K
- Opioid Claims
- 31 (3.1% rate)
- Antibiotic Claims
- 17
Patient Demographics
- Average Patient Age
- 73.6 years
- Avg HCC Risk Score
- 1.98
- Gender Split
- 77% female / 23% male
- Age Distribution
- <65: 13, 65-74: 103, 75-84: 74, 85+: 17
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Shantae Lucas, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Anastrozole
Anastrozole
166 claims
- Letrozole
Letrozole
90 claims
- Eliquis 49
Eliquis
49 claims
- Gabapentin 42
Gabapentin
42 claims
- Revlimid 32
Revlimid
32 claims
- Hydroxyurea 30
Hydroxyurea
30 claims
- Levothyroxine Sodium 29
Levothyroxine Sodium
29 claims
- Prednisone 29
Prednisone
29 claims
| Drug | Claims |
|---|---|
| Anastrozole | 166 |
| Letrozole | 90 |
| Eliquis Apixaban | 49 |
| Gabapentin | 42 |
| Revlimid Lenalidomide | 32 |
| Hydroxyurea | 30 |
| Levothyroxine Sodium | 29 |
| Prednisone | 29 |
| Imatinib Mesylate | 26 |
| Jakafi Ruxolitinib Phosphate | 21 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How Shantae Lucas, MD fits within the Medical Oncology Physician landscape nationally.
3,815
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider
Shantae Lucas, MD's 1,009 claims are above the specialty average of 689.
Nearby Medical Oncology Physician Providers in North Carolina
Other clinicians with the same primary specialty enrolled in North Carolina, drawn from the same CMS NPPES roster as Lucas.
Dr. Amy Abernethy
M.D.
Durham, NC
Dr. Neeraj Agrawal
MD
Raleigh, NC
Dr. Maleka Ahmed
MD
Lumberton, NC
Laura Alder
Durham, NC
Dr. Carey Anders
M.D.
Chapel Hill, NC
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the North Carolina medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Medical Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore North Carolina
Frequently Asked Questions
What is Shantae Lucas, MD's specialty? ▼
Shantae Lucas, MD specializes in Medical Oncology Physician and practices in Asheville, North Carolina. Credentials: MD.
How much does Shantae Lucas, MD prescribe under Medicare Part D? ▼
In 2023, Shantae Lucas, MD wrote 1,009 Medicare Part D claims totaling $2.3M in drug costs for 207 beneficiaries.
What is Shantae Lucas, MD's Medicare quality score? ▼
Shantae Lucas, MD has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Shantae Lucas, MD located? ▼
Shantae Lucas, MD is located at 551 BREVARD RD, Asheville, NC, 28806. Phone: (828) 212-7021.
What is Shantae Lucas, MD's NPI number? ▼
Shantae Lucas, MD's National Provider Identifier (NPI) is 1063402998, issued on 10/22/2005.
Does Shantae Lucas, MD prescribe more brand-name or generic drugs? ▼
Shantae Lucas, MD's prescribing is 21% brand-name and 79% generic drugs by claim count, with $2.2M in brand drug costs.
Does Shantae Lucas, MD prescribe opioids? ▼
Yes, Shantae Lucas, MD had 31 opioid claims in 2023 with an opioid prescribing rate of 3.1%.
How many Medical Oncology Physician providers are there in the US? ▼
There are 3,815 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does Shantae Lucas, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Shantae Lucas, MD's most frequently prescribed drugs include Anastrozole, Letrozole, Eliquis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Shantae Lucas, MD accept Medicare? ▼
Shantae Lucas, MD appears in CMS Medicare data with 1,009 Part D claims and 207 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Shantae Lucas, MD's credentials? ▼
Shantae Lucas, MD's NPI is 1063402998 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.